发明名称 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1
摘要 The present invention provides a compound a formula (I); or a pharmaceutically acceptable salt thereof, wherein: X is CH, O, S or-NR; each R are independently Calkyl or Ccycloalkyl; each of R and R are independently hydrogen, halogen, cyano, Calkyl, hydroxy-Calkyl, -OR, Ccycloalkyl, halo-Calkyl or -CH-NR-SO-R; R and R are independently hydrogen, halogen or cyano; R is hydrogen, Calkyl, halogen, cyano, hydroxy, hydroxy-Calkyl, hydroxy-C cycloalkylalkyl, Calkoxy-Calkyl, -OR, Caryl, heteroaryl, heterocyclyl, C cycloalkyl, halo- Calkyl, -NRR, -CHNR-C(O)NRR, -CH-NR-SO-R, -C(O)- R, -SOR, -C(O)-NRR -SO-NRR, -NRC(O)-R -CHCN, or -NR-SO-R. Compounds of the invention may be useful in the treatment of a disorder or disease mediated by aldosterone synthase and/or 11-beta hydroxylase (CYP1 181).
申请公布号 AU2010247412(A1) 申请公布日期 2011.11.24
申请号 AU20100247412 申请日期 2010.05.12
申请人 NOVARTIS AG 发明人 ADAMS, CHRISTOPHER MICHAEL;CHAMOIN, SYLVIE;HU, QI-YING;ZHANG, CHUN
分类号 C07D401/04;A61K31/4439;C07D401/14;C07D405/14;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/14 主分类号 C07D401/04
代理机构 代理人
主权项
地址